Viewing Study NCT00834132


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT00834132
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2009-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Azithromycin 600 Mg Tablets, Fed
Sponsor: Teva Pharmaceuticals USA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-07
Start Date Type: None
Primary Completion Date: 2002-08
Primary Completion Date Type: ACTUAL
Completion Date: 2002-08
Completion Date Type: ACTUAL
First Submit Date: 2009-01-30
First Submit QC Date: None
Study First Post Date: 2009-02-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-05-07
Results First Submit QC Date: None
Results First Post Date: 2009-08-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-15
Last Update Post Date: 2024-08-19
Last Update Post Date Type: ACTUAL